DR. NIKHIL PALEKAR – NEW ALZHEIMER’S DRUG “LAQEMBI” - 8 19 23

THE FDA RECENTLY GAVE FULL APPROVAL TO A NEW DRUG CALLED LEQEMBI, WHICH IS BEING HAILED AS “A NEW ERA IN ALZHEIMER’S TREATMENT”. WE SPEAK WITH NIKHIL PALEKAR, MD - DIRECTOR OF THE <i>STONY BROOK CENTER OF EXCELLENCE FOR ALZHEIMER’S DISEASE </i>AND<i> </i>DIRECTOR OF<i> THE STONY BROOK ALZHEIMER’S DISEASE CLINICAL TRIALS PROGRAM</i> TO DISCUSS THE DETAILS. <i> </i>